Chemically Modified Polyelectrolytes for Intestinal Peptide and Protein Delivery

Peptide and Protein Delivery

Volumn , Issue , 2011, Pages 123-164

  Thompson, Colin ^a   Cheng, Woei Ping ^b  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81255145144     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384935-9.10007-0     Document Type: Chapter

References (103)

1. S. Mao, O. Germershaus, D. Fischer, T. Linn, R. Schnepf and T. Kissel (2005) Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm. Res. 22 2058-2068.
2. S.M. Hartig, R.R. Greene, M.M. Dikov, A. Prokop and J.M. Davidson (2007) Multifunctional nanoparticulate polyelectrolyte complexes. Pharm. Res. 24 2353-2369.
3. C. Weber, A. Drogoz, L. David, A. Domard, M.-H. Charles, B. Verrier, et al. (2010) Polysaccharide-based vaccine delivery systems: Macromolecular assembly, interactions with antigen presenting cells, and in vivo immunomonitoring. J. Biomed. Mater. Res. A 93 1322-1334.
4. K. Bowman and K.W. Leong (2006) Chitosan nanoparticles for oral drug and gene delivery. Int. J. Nanomed. 1 117-128.
5. M. George and T. Abraham (2006) Emilia, Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan – a review. J. Control. Release 114 1-14.
6. M. de la Fuente, N. Csaba, M. Garcia-Fuentes and M.J. Alonso (2008) Nanoparticles as protein and gene carriers to mucosal surfaces. Nanomedicine 3 845-857.
7. M. Werle, H. Takeuchi and A. Bernkop-Schnurch (2009) Modified chitosans for oral drug delivery. J. Pharm. Sci. 98 1643-1656.
8. M. Amidi, E. Mastrobattista, W. Jiskoot and W.E. Hennink (2010) Chitosan based delivery systems for protein therapeutics and antigens. Adv. Drug Deliv. Rev. 62 59-82.
9. H. Dautzenberg (1997) Polyelectrolyte complex formation in highly aggregating systems 1. Effect of salt: Polyelectrolyte complex formation in the presence of NaCl. Macromolecules 30 7810-7815.
10. A. Shovsky, I. Varga, R. Makuska and P.M. Claesson (2009) Formation and stability of water soluble, molecular polyelectrolyte complexes: Effects of charge density, mixing ratio, and polyelectrolyte concentration. Langmuir 25 6113-6121.
11. S. Sakuma, R. Sudo, N. Suzuki, H. Kikuchi, M. Akashi and M. Hayashi (1999) Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int. J. Pharm. 177 161-172.
12. M. Thanou, J.C. Verhoef, P. Marbach and H.E. Junginger (2000) Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J. Pharm. Sci. 89 951-957.
13. D. Guggi, C.E. Kast and A. Bernkop-Schnurch (2003) In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix. Pharm. Res. 20 1989-1994.
14. D. Guggi, A.H. Krauland and A. Bernkop-Schnurch (2003) Systemic peptide delivery via the stomach: In vivo evaluation of an oral dosage form for salmon calcitonin. J. Control. Release 92 125-135.
15. A.H. Krauland and M.J. Alonso (2007) Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm. 340 134-142.
16. C.B. Packhaeuser and T. Kissel (2007) On the design of an in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. J. Control. Release 123 131-140.
17. M. Simon, I. Behrens, L.A. Dailey, M. Wittmar and T. Kissel (2007) Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[(vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(l-lactic acid): Protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity. Eur. J. Pharm. Biopharm. 66 165-172.
18. G. Perera, M. Greindl, T. Palmberger and A. Bernkop-Schnurch (2009) Insulin-loaded poly(acrylic acid)–cysteine nanoparticles: Stability studies towards digestive enzymes in the intestine. Drug Deliv. 16 254-260.
19. A. Jintapattanakit, V.B. Junyaprasert, S. Mao, J. Sitterberg, U. Bakowsky and T. Kissel (2007) Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int. J. Pharm. 342 240-249.
20. M. Huang, S.N. Vitharana, L.J. Peek, T. Coop and C. Berkland (2007) Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules 8 1607-1614.
21. A.M.M. Sadeghi, F.A. Dorkoosh, M.R. Avadi, P. Saadat, M. Rafiee-Tehrani and H.E. Junginger (2008) Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both ionotropic gelation and polyelectrolyte complexation methods. Int. J. Pharm. 355 299-306.
22. S. Dragan, M. Cristea, C. Luca and B.C. Simionescu (1996) Polyelectroylte complexes. 1. Synthesis and characterisation of some insoluble polyanion–polycation complexes. J. Polym. Sci. Pol. Chem. 34 3485-3494.
23. C. Tribet (1999) Complexation between amphiphilic polyelectrolytes and proteins: From necklaces to gels. R. Tsetska (Ed.) Physical Chemistry of Polyelectrolytes, Surfactant Science Series Vol. 99 New York: Marcel Dekker Inc. 687-741.
24. S. Sakuma, M. Hayashi and M. Akashi (2001) Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv. Drug Deliv. Rev. 47 21-37.
25. C.J. Thompson, L. Tetley, I.F. Uchegbu and W.P. Cheng (2009) The complexation between novel comb shaped amphiphilic polyallylamine and insulin – Towards oral insulin delivery. Int. J. Pharm. 376 46-55.
26. C.J. Thompson, L. Tetley and W.P. Cheng (2010) The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allyl amine) against in vitro enzymatic degradation of insulin – Towards oral insulin delivery. Int. J. Pharm. 383 216-227.
27. C.L. Cooper, P.L. Dubin, A.B. Kayitmazer and S. Turksen (2005) Polyelectrolyte–protein complexes. Curr. Opin. Colloid Interface Sci. 10 52-78.
28. M. Simon, M. Wittmar, U. Bakowsky and T. Kissel (2004) Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(l-lactic acid): A novel carrier for transmucosal delivery of peptides. Bioconjugate Chem. 15 841-849.
29. S. Sakuma, N. Suzuki, H. Kikuchi, K. Hiwatari, K. Arikawa, A. Kishida, et al. (1997) Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches. Int. J. Pharm. 149 93-106.
30. K. Gupta, M. Ganguli, S. Pasha and S. Maiti (2006) Nanoparticle formation from poly(acrylic acid) and oppositely charged peptides. Biophys. Chem. 119 303-306.
31. L. Yin, J. Ding, C. He, L. Cui, C. Tang and C. Yin (2009) Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 30 5691-5700.
32. A. Wittemann, T. Azzam and A. Eisenberg (2007) Biocompatible polymer vesicles from biamphiphilic triblock copolymers and their interaction with bovine serum albumin. Langmuir 23 2224-2230.
33. K.-M. Jin and Y.-H. Kim (2008) Injectable, thermo-reversible and complex coacervate combination gels for protein drug delivery. J. Control. Release 127 249-256.
34. C.J. Thompson, C. Ding, X. Qu, Z. Yang, I.F. Uchegbu, L. Tetley, et al. (2008) The effect of polymer architecture on the nano self-assemblies based on novel comb-shaped amphiphilic poly(allylamine). Colloid Polym. Sci. 286 1511-1526.
35. W. Wang, L. Tetley and I.F. Uchegbu (2001) The level of hydrophobic substitution and the molecular weight of amphiphilic poly-l-lysine-based polymers strongly affects their assembly into polymeric bilayer vesicles. J. Colloid Interface Sci. 237 200-207.
36. W. Wang, X.Z. Qu, A.I. Gray, L. Tetley and I.F. Uchegbu (2004) Self-assembly of cetyl linear polyethylenimine to give micelles, vesicles and dense nanoparticles. Macromolecules 37 9114-9122.
37. W.P. Cheng, A.I. Gray, L. Tetley, T.L.B. Hang, A.G. Schatzlein and I.F. Uchegbu (2006) Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds. Biomacromolecules 7 1509-1520.
38. X.Z. Qu, L. Omar, T.B. Hang Le, L. Tetley, K. Bolton, K.W. Chooi, et al. (2008) Polymeric amphiphile branching leads to rare nanodisc shaped planar self-assemblies. Langmuir 24 9997-10004.
39. G. Kwon. and T. Okano (1996) Polymeric micelles as new drug carriers. Adv. Drug Deliv. Rev. 21 107-116.
40. M. Talelli, C.J.F. Rijcken, C.F. van Nostrum, G. Storm and W.E. Hennink (2010) Micelles based on HPMA copolymers. Adv. Drug Deliv. Rev. 62 231-239.
41. M. Yokoyama (2010) Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Expert Opin. Drug Deliv. 7 145-158.
42. W.P. Cheng, C.J. Thompson, S.M. Ryan, T. Aguirre, L. Tetley and D.J. Brayden (2010) In vitro and in vivo characterisation of a novel peptide delivery system: Amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes. J. Control. Release 147 289-297.
43. C.J. Thompson, R. Knott and W.P. Cheng (2009) The use of quaternised amphiphilic polymer to modify insulin uptake in Caco-2 cells towards oral insulin. J. Pharm. Pharmacol. 61(Suppl 1), A40-A41.
44. A. Breitenbach and T. Kissel (1998) Biodegradable comb polyesters: Part I. Synthesis, characterization and structural analysis of poly (lactide) and poly (lactide-co-glycolide) grafted onto water-soluble poly (vinyl alcohol) as backbone. Polymer 39 3261-3271.
45. A. Breitenbach, K.F. Pistel and T. Kissel (2000) Biodegradable comb polyesters: Part II. Erosion and release properties of poly (vinyl alcohol)-g-poly (lactide-co-glycolide). Polymer 41 4781-4792.
46. T. Jung, A. Breitenbach and T. Kissel (2000) Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres. J. Control. Release 67 157-169.
47. L.A. Dailey, M. Wittmar and T. Kissel (2005) The role of branched polyesters and their modifications in the development of modern drug delivery vehicles. J. Control. Release 101 137-149.
48. M. Simon, M. Wittmar, T. Kissel and T. Linn (2005) Insulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(l-lactide): Bioavailability and nasal tolerability in rats. Pharm. Res. 22 1879-1886.
49. S. Sakuma, N. Suzuki, H. Kikuchi, K. Hiwatari, K. Arikawa, A. Kishida, et al. (1997) Absorption enhancement of orally administered salmon calcitonin by polystyrene nanoparticles having poly(N-isopropylacrylamide) branches on their surfaces. Int. J. Pharm. 158 69-78.
50. S. Sakuma, N. Suzuki, H. Kikuchi, K. Hiwatari, K. Arikawa, A. Kishida, et al. (1997) Stabilization of salmon calcitonin by polystyrene nanoparticles having surface hydrophilic polymeric chains, against enzymatic degradation. Int. J. Pharm. 159 181-189.
51. S. Sakuma, N. Suzuki, R. Sudo, K. Hiwatari, A. Kishida and M. Akashi (2002) Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin. Int. J. Pharm. 239 185-195.
52. S. Sakuma, R. Sudo, N. Suzuki, H. Kikuchi, M. Akashi, Y. Ishida, et al. (2002) Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine. J. Control. Release 81 281-290.
53. R.J. Schilling and A.K. Mitra (1991) Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm. Res. 8 721-727.
54. P. Calceti, S. Salmaso, G. Walker and A. Bernkop-Schnurch (2004) Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur. J. Pharm. Sci. 22 315-323.
55. C.J. Thompson, W.P. Cheng, P. Gadad, K. Skene, M. Smith, G. Smith, et al., Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells – towards oral insulin. In preparation.
56. J. Xia, P.L. Dubin, Y. Kim, B.B. Muhoberac and V.J. Klimkowski (1993) Electrophoretic and quasi-elastic light scattering of soluble protein–polyelectrolyte complexes. J. Phys. Chem. 97 4528-4534.
57. S. Gautier, M. Boustta and M. Vert (1999) Alkylated poly(l-lysine citramide) as models to investigate the ability of amphiphilic macromolecular drug carriers to physically entrap lipophilic compounds in aqueous media. J. Control. Release 60 235-427.
58. M.A.H. Capelle, R. Gurny and T. Arvinte (2009) A high throughput protein formulation platform: Case study of salmon calcitonin. Pharm. Res. 26 18-128.
59. E.S. Lee, K.-H. Park, D. Kang, I.S. Park, H.Y. Min, D.H. Lee, et al. (2007) Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres. Biomaterials 28 2754-2762.
60. K.F. Pistel, A. Breitenbach, R. Zange-Volland and T. Kissel (2001) Brush-like branched biodegradable comb polyesters: Part III. Protein release from microspheres of poly (vinyl alcohol)-graft-poly (d, l-lactic-co-glycolic acid). J. Control. Release 73 7-20.
61. V.K. Mourya and N.N. Inamdar (2008) Chitosan-modifications and applications: Opportunities galore. React. Funct. Polym. 68 1013-1051.
62. A. Bernkop-Schnürch and G. Walker (2001) Multifunctional matrices for oral peptide delivery. Crit. Rev. Ther. Drug Carr. Syst. 18 459-501.
63. M. Thanou, J.C. Verhoef and H.E. Junginger (2001) Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 52 117-126.
64. A.F. Kotzé, H.L. Leuβen, B.J. de Leeuw, B.G. de Boer, J.C. Verhoef and H.E. Junginger (1997) N–Trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2). Pharm. Res. 14 1197-1202.
65. H.L. Leuβen, C.O. Rentel, A.F. Kotzé, C.-M. Lehr, A.G. de Boer, J.C. Verhoef, et al. (1997) Mucoadhesive polymers in peroral peptide drug delivery. IV: Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J. Control. Release 45 14-23.
66. L. Illum, N.F. Farraj and S.S. Davis (1994) Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11 1186-1189.
67. T.J. Aspden, L. Illum and Ø. Skaugrud (1996) Chitosan as a nasal delivery system: Evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci. 4 23-31.
68. A.M. Dryer, M. Hinchcliffe, P. Watts, J. Castile, I. Jabbal-Gill, R. Nankervis, et al. (2002) Nasal delivery of insulin using novel chitosan formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm. Res. 19 998-1008.
69. H.L. Leuβen, B.J. de Leeuw, M.W.E. Langemeyer, A.G. de Boer, J.C. Verhoef and H.E. Junginger (1996) Mucoadhesive polymers in peroral drug delivery VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 13 1666-1670.
70. C.-M. Lehr, J.A. Bouwstra, E.H. Schacht and H.E. Junginger (1992) In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78 43-48.
71. C.-M. Lehr, J.A. Bouwstra and H.E. Junginger (1993) A surface energy analysis of mucoadhesive performance by spreading coefficients. Eur. J. Pharm. Sci. 1 19-30.
72. A.F. Kotzé, B.J. de Leeuw, H.L. Leuβen, A.G. de Boer, J.C. Verhoef and H.E. Junginger (1997) Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: In vitro evaluation in Caco-2 cell monolayers. Int. J. Pharm. 159 243-253.
73. I.M. van der Lubben, J.C. Verhoef, G. Borchard and H.E. Junginger (2001) Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci. 14 201-207.
74. M.M. Thanou, A.F. Kotzé, T. Scharringhausen, H.L. Leuβen, A.G. de Boer, J.C. Verhoef, et al. (2000) Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers. J. Control. Release 64 15-25.
75. A.M.M. Sadeghi, F.A. Dorkoosh, M.R. Avadi, M. Weinhold, A. Bayat, F. Delie, et al. (2008) Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur. J. Pharm. Biopharm. 70 270-278.
76. A.F. Kotzé, H.L. Leuβen, A.G. de Boer, J.C. Verhoef and H.E. Junginger (1998) Chitosan for enhanced intestinal permeability prospects for derivatives soluble in neutral and basic environments. Eur. J. Pharm. Sci. 7 145-151.
77. M. Thanou, B.I. Florea, M.W.E. Langemeyer, J.C. Verhoef and H.E. Junginger (2000) N-Trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug Buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharm. Res. 17 27-31.
78. A.F. Kotzé, H.L. Leuβen, B.J. de Leeuw, B.G. de Boer, J.C. Verhoef and H.E. Junginger (1998) Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Control. Release 51 35-46.
79. M. Werle and M. Hoffer (2006) Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J. Control. Release 111 41-46.
80. A. Bayat, F.A. Dorkoosh, A.R. Dehpour, L. Moezi, B. Larijani, H.E. Junginger, et al. (2008) Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: Ex vivo and in vivo studies. Int. J. Pharm. 356 259-266.
81. M. Thanou, J.C. Verhoef, J.H.M. Verheijden and H.E. Junginger (2001) Intestinal absorption of octreotide using trimethyl chitosan chloride: Studies in pigs. Pharm. Res. 18 823-828.
82. S.M. van der Merwe, J.C. Verhoef, A.F. Kotzé and H.E. Junginger (2004) N-Trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations. Eur. J. Pharm. Biopharm. 57 85-91.
83. S.M. van der Merwe, J.C. Verhoef, J.H.M. Verheijden, A.F. Kotzé and H.E. Junginger (2004) Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur. J. Pharm. Biopharm. 58 225-235.
84. A. Domard, M. Rinaudo and C. Terrassin (1986) New method for the quaternization of chitosan. Int. J. Biol. Macromol. 8 105-107.
85. C. Jonker, J.H. Hamman and A.F. Kotzé (2002) Intestinal paracellular permeation enhancement with quaternized chitosan: In situ and in vitro evaluation. Int. J. Pharm. 238 205-213.
86. J.H. Hamman, C.M. Schultz and A.F. Kotzé (2003) N-trimethyl chitosan chloride: Optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev. Ind. Pharm. 29 161-172.
87. D. Synman, J.H. Hamman and A.F. Kotzé (2003) Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride. Drug Dev. Ind. Pharm. 29 59-67.
88. P. Artursson, T. Lindmark, S.S. Davis and L. Illum (1994) Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11 1358-1361.
89. H. Lennernas, K. Palm, U. Fagerholm and P. Artursson (1996) Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm. 127 103-107.
90. T. Lindmark, N.G. Schipper, L. Lazorova, A.G. de Boer and P. Artursson (1998) Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: Assessment of molecular weight dependence and demonstration of transport routes. J. Drug Target. 5 215-223.
91. N.G.M. Schipper, K.M. Varum, P. Stenberg, G. Ocklind, H. Lennernas and P. Artursson (1999) Chitosans as absorption enhancers of poorly soluble drugs: 3: Influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8 335-343.
92. H.L. Lueßen, B.J. de Leeuw, D. Pérard, C.-M. Lehr, A.G. de boer, J.C. Verhoef, et al. (1996) Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes. Eur. J. Pharm. Sci. 4 117-128.
93. A. Vila, A. Sanchez, M. Tobio, P. Calvo and M.J. Alonso (2002) Design of biodegradable particles for protein delivery. J. Control. Release 78 15-24.
94. N. Rouge, E.T. Cole, E. Doelker and P. Buri (1997) Screening of potentially floating excipients for minitablets. STP Pharma Sci. 7 386-392.
95. N. Rouge, J.-C. Leroux, E.T. Cole, E. Doelker and P. Buri (1997) Prevention of the sticking tendency of floating minitablets filled into hard gelatin capsules. Eur. J. Pharm. Biopharm. 43 165-171.
96. W.A. Chan, C.D. Boswell and Z. Zhang (2001) Comparison of the release profiles of a water soluble drug carried by Eudragit-coated capsules in different in vitro dissolution liquids. Powder Technol. 119 26-32.
97. A. Bernkop-Schnürch, M. Hornof and T. Zoidl (2003) Thiolated polymers–thiomers: Synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int. J. Pharm. 260 229-237.
98. A. Bernkop-Schnurch, A.H. Krauland, V.M. Leitner and T. Palmberger (2004) Thiomers: Potential excipients for non-invasive peptide delivery systems. Eur. J. Pharm. Biopharm. 58 253-263.
99. V.M. Leitner, G.F. Walker and A. Bernkop-Schnurch (2003) Thiolated polymers: Evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm. 56 207-214.
100. M. Roldo, M. Hornof, P. Caliceti and A. Bernkop-Schnurch (2004) Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: Synthesis and in vitro evaluation. Eur. J. Pharm. Biopharm. 57 115-121.
101. K. Kafedjiiski, A.H. Krauland, M.H. Hoffer and A. Bernkop-Schnurch (2005) Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials 26 819-826.
102. A. Bernkop-Schnurch, G. Walker and H. Zarti (2001) Thiolation of polycarbophil enhances its inhibition of intestinal brush border membrane bound aminopeptidase N. J. Pharm. Sci. 90 1907-1914.
103. A.H. Krauland, D. Guggi and A. Bernkop-Schnurch (2004) Oral insulin delivery: The potential of thiolated chitosan-insulin tablets on non-diabetic rats. J. Control. Release 95 547-555.